Stay ahead of change

Explore our research, insights, and examples of real client impact, designed to help you embrace the key

Filters
Industry
Quantilityy - AI Medicine

Generative AI: The Next Frontier for Health Care Operations

About 25% of biopharma firms and 10% of medtech players already report tangible business value from AI, including cost reductions and revenue increases of at least 5%. These early adopters are also seeing measurable improvements in speed, compliance, and agility. In contrast, nearly 60% of manufacturers remain cautious, with no clear GenAI strategy or at best, a wait-and-see stance.